Published in Proc Natl Acad Sci U S A on February 20, 2007
Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88
The DNA-damage response in human biology and disease. Nature (2009) 17.86
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24
Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell (2010) 8.79
Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res (2013) 7.41
Progress and prospects: zinc-finger nucleases as gene therapy agents. Gene Ther (2008) 7.28
TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol (2012) 7.01
Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One (2009) 6.67
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59
An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19
High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods (2011) 5.68
Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol (2010) 5.60
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature (2009) 4.71
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res (2010) 3.94
Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 3.70
Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Mol Ther (2008) 3.02
Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays. Nat Protoc (2009) 3.01
Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res (2013) 2.99
Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nat Protoc (2009) 2.67
Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res (2010) 2.61
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet (2009) 2.18
Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res (2012) 2.12
Modular system for the construction of zinc-finger libraries and proteins. Nat Protoc (2010) 1.87
Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging. Circ Res (2012) 1.84
Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther (2011) 1.76
Translating dosage compensation to trisomy 21. Nature (2013) 1.75
Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One (2011) 1.69
Custom-designed zinc finger nucleases: what is next? Cell Mol Life Sci (2007) 1.63
Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res (2011) 1.59
Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA. Nucleic Acids Res (2008) 1.48
Navigational mechanisms of migrating monarch butterflies. Trends Neurosci (2010) 1.42
Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41
Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31
Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res (2014) 1.26
Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res (2011) 1.25
Gene targeting in the rat: advances and opportunities. Trends Genet (2010) 1.25
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat Biotechnol (2015) 1.17
Safeguarding nonhuman primate iPS cells with suicide genes. Mol Ther (2011) 1.16
Quantifying on- and off-target genome editing. Trends Biotechnol (2015) 1.15
Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther (2011) 1.12
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. Mol Ther (2013) 1.10
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR. Mol Cell (2015) 1.09
Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res (2012) 1.09
Zinc-finger nucleases: how to play two good hands. Nat Methods (2011) 1.08
Nontransgenic genome modification in plant cells. Plant Physiol (2010) 1.08
p53 Gene repair with zinc finger nucleases optimised by yeast 1-hybrid and validated by Solexa sequencing. PLoS One (2011) 1.04
Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors. Hum Gene Ther (2011) 1.04
Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease. Mol Ther (2010) 1.04
A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells. Nucleic Acids Res (2013) 1.04
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease. Nat Biotechnol (2016) 1.03
Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum Gene Ther (2008) 1.01
Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA. Nat Protoc (2010) 0.99
Group II intron-based gene targeting reactions in eukaryotes. PLoS One (2008) 0.98
Emerging gene knockout technology in zebrafish: zinc-finger nucleases. Brief Funct Genomic Proteomic (2008) 0.95
Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol (2012) 0.94
Zinc-finger nucleases: new strategies to target the rat genome. Clin Sci (Lond) (2010) 0.93
Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases. Stem Cells Dev (2012) 0.93
Genome editing with CompoZr custom zinc finger nucleases (ZFNs). J Vis Exp (2012) 0.93
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases. Mol Ther Nucleic Acids (2013) 0.92
Progress and prospects: techniques for site-directed mutagenesis in animal models. Gene Ther (2009) 0.92
Targeted gene therapies: tools, applications, optimization. Crit Rev Biochem Mol Biol (2012) 0.91
Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells. PLoS One (2011) 0.91
Genetic therapies for cystic fibrosis lung disease. Hum Mol Genet (2011) 0.91
Genome editing in human stem cells. Methods Enzymol (2014) 0.89
Analysis of illegitimate genomic integration mediated by zinc-finger nucleases: implications for specificity of targeted gene correction. BMC Mol Biol (2010) 0.89
TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery. Acta Naturae (2014) 0.89
Pluripotent stem cells and gene therapy. Transl Res (2013) 0.88
Nonhomologous end joining-mediated gene replacement in plant cells. Plant Physiol (2013) 0.88
Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases. Hum Genet (2016) 0.88
Creation of a type IIS restriction endonuclease with a long recognition sequence. Nucleic Acids Res (2009) 0.87
Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells. Nucleic Acids Res (2013) 0.87
Customizing the genome as therapy for the β-hemoglobinopathies. Blood (2016) 0.85
Expression and purification of BmrI restriction endonuclease and its N-terminal cleavage domain variants. Protein Expr Purif (2007) 0.84
Rational design of a chimeric endonuclease targeted to NotI recognition site. Protein Eng Des Sel (2007) 0.84
Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Mol Ther Nucleic Acids (2013) 0.84
Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic Acids Res (2013) 0.83
Towards a new era in medicine: therapeutic genome editing. Genome Biol (2015) 0.83
Sequence conversion by single strand oligonucleotide donors via non-homologous end joining in mammalian cells. J Biol Chem (2010) 0.83
Origins of Programmable Nucleases for Genome Engineering. J Mol Biol (2015) 0.83
Custom-designed molecular scissors for site-specific manipulation of the plant and mammalian genomes. Methods Mol Biol (2009) 0.82
TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Sci Rep (2016) 0.81
A platform for rapid prototyping of synthetic gene networks in mammalian cells. Nucleic Acids Res (2014) 0.81
Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesign. J Am Chem Soc (2014) 0.81
An asymmetric PCR-based, reliable and rapid single-tube native DNA engineering strategy. BMC Biotechnol (2012) 0.81
The potential for genetically altered microglia to influence glioma treatment. CNS Neurol Disord Drug Targets (2013) 0.80
Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids (2015) 0.80
Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification. Mol Ther Nucleic Acids (2013) 0.80
Recent advances in gene therapy for severe congenital immunodeficiency diseases. Curr Opin Hematol (2008) 0.80
Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome. Dis Model Mech (2013) 0.80
Zinc Finger Nucleases: Tailor-made for Gene Therapy. Drugs Future (2012) 0.79
Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy. Mol Ther (2016) 0.78
Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones. J Biomed Sci (2015) 0.78
Reshaping pluripotent stem cells. Nat Biotechnol (2009) 0.77
Conditional gene vectors regulated in cis. Nucleic Acids Res (2008) 0.77
Lung gene therapy-How to capture illumination from the light already present in the tunnel. Genes Dis (2014) 0.77
THE REPLICATION OF DNA IN ESCHERICHIA COLI. Proc Natl Acad Sci U S A (1958) 20.58
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39
Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1999) 19.25
Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature (2005) 19.15
Genome maintenance mechanisms for preventing cancer. Nature (2001) 16.17
Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science (1991) 15.97
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A (1996) 12.25
Chimeric nucleases stimulate gene targeting in human cells. Science (2003) 12.12
Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair. Microbiol Mol Biol Rev (2002) 8.50
Enhancing gene targeting with designed zinc finger nucleases. Science (2003) 8.42
Design and selection of novel Cys2His2 zinc finger proteins. Annu Rev Biochem (2001) 7.79
Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol (2003) 6.96
High frequency targeting of genes to specific sites in the mammalian genome. Cell (1986) 6.91
Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol (2001) 6.68
Efficient copying of nonhomologous sequences from ectopic sites via P-element-induced gap repair. Mol Cell Biol (1994) 6.24
Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol (1994) 6.08
Sensing and repairing DNA double-strand breaks. Carcinogenesis (2002) 5.52
Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci U S A (1994) 5.37
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol (1998) 4.46
Regulation and mechanisms of mammalian double-strand break repair. Oncogene (2003) 4.43
Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res (2004) 3.46
Expressing the human genome. Nature (2001) 3.45
In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature (1994) 3.31
Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol Cell (2005) 3.16
A means to a DNA end: the many roles of Ku. Nat Rev Mol Cell Biol (2004) 3.07
Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol Cell (2005) 2.88
A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res (1999) 2.54
Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer (2003) 2.08
Role of DNA replication proteins in double-strand break-induced recombination in Saccharomyces cerevisiae. Mol Cell Biol (2004) 1.87
Differential usage of alternative pathways of double-strand break repair in Drosophila. Genetics (2005) 1.63
Therapeutic gene targeting. Gene Ther (1998) 1.55
Gene targeting with viral vectors. Mol Ther (2005) 1.42
Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol (2006) 1.42
Conservative inheritance of newly synthesized DNA in double-strand break-induced gene conversion. Mol Cell Biol (2006) 1.32
Gene therapy: the moving finger. Nature (2005) 1.13
Site-specific integration with phiC31 integrase for prolonged expression of therapeutic genes. Adv Genet (2005) 1.08
Biallelic transcription of Igf2 and H19 in individual cells suggests a post-transcriptional contribution to genomic imprinting. Curr Biol (1999) 0.97
Homologous recombination is promoted by translesion polymerase poleta. Mol Cell (2005) 0.96
Gene regulatory proteins and their interaction with DNA. Ann N Y Acad Sci (1995) 0.93
Biotechnologies and therapeutics: chromatin as a target. Curr Opin Genet Dev (2002) 0.87
A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47
Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature (2005) 19.15
Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88
An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol (2007) 17.80
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol (2008) 14.75
Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol (2008) 14.20
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33
Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76
Targeted genome editing across species using ZFNs and TALENs. Science (2011) 9.84
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol (2007) 9.23
Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell (2010) 8.79
Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med (2014) 7.64
A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol (2010) 6.77
Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44
Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods (2010) 6.00
Histone deimination antagonizes arginine methylation. Cell (2004) 5.19
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature (2009) 4.71
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res (2010) 3.94
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res (2000) 3.84
Transient cold shock enhances zinc-finger nuclease-mediated gene disruption. Nat Methods (2010) 3.59
Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem (2001) 3.38
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A (1997) 3.00
Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell (2012) 2.87
Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells. Nat Cell Biol (2011) 2.79
Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 2.61
Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res (2010) 2.61
TRF2 associates with DREF and directs promoter-selective gene expression in Drosophila. Nature (2002) 2.48
Targeted transgene integration in plant cells using designed zinc finger nucleases. Plant Mol Biol (2008) 2.40
Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods (2011) 2.30
Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A (2003) 2.24
Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng (2010) 2.23
The natural history of the NZB/NZW F1 hybrid mouse: a laboratory model of systemic lupus erythematosus. Australas Ann Med (1965) 2.23
DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet (2011) 2.22
Genetic investigations of autoimmune disease in mice. Nature (1965) 2.18
Identification of chromosome sequence motifs that mediate meiotic pairing and synapsis in C. elegans. Nat Cell Biol (2009) 2.15
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem (2001) 2.11
Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res (2012) 2.02
Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol (2002) 1.90
Efficient targeted gene disruption in the soma and germ line of the frog Xenopus tropicalis using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 1.90